Bloomage Deferred Long Term Liab from 2010 to 2024
| 688363 Stock | 59.16 1.32 2.28% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 36.6 M | Current Value 38.5 M | Quarterly Volatility 15.1 M |
Check Bloomage Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bloomage Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 11.3 M, Other Operating Expenses of 6.3 B or Net Income Applicable To Common Shares of 562.4 M, as well as many indicators such as . Bloomage financial statements analysis is a perfect complement when working with Bloomage Biotechnology Valuation or Volatility modules.
Bloomage | Deferred Long Term Liab |
Currently Active Assets on Macroaxis
Other Information on Investing in Bloomage Stock
Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.